(DEO) Diageo - Overview
Stock: Whisky, Vodka, Rum, Liqueur, Beer
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.07% |
| Yield on Cost 5y | 2.90% |
| Yield CAGR 5y | 0.76% |
| Payout Consistency | 93.2% |
| Payout Ratio | 21.8% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.9% |
| Relative Tail Risk | -7.22% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.40 |
| Alpha | -17.45 |
| Character TTM | |
|---|---|
| Beta | 0.337 |
| Beta Downside | 0.125 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.01% |
| CAGR/Max DD | -0.29 |
Description: DEO Diageo January 29, 2026
Diageo plc (NYSE: DEO) is a London-based global alcoholic-beverages group operating across North America, Europe, Asia-Pacific, Latin America, the Caribbean and Africa. Its portfolio spans beer, whisky, gin, vodka, rum, liqueur, wine and ready-to-drink formats, anchored by marquee brands such as John Walker, Guinness, Smirnoff, Baileys, Don Julio and Crown Royal.
In the most recent quarter (Q3 2024), Diageo reported net sales of $7.1 billion, up 5.2 % year-over-year, driven by a 9 % premium-spirits volume increase in emerging markets and a 4 % price-realization gain in North America. Adjusted operating margin held steady at 22.5 %, while free cash flow reached $1.8 billion, supporting a 3.2 % dividend yield and a 10-year dividend growth streak. The sector is currently influenced by three macro-drivers: (1) sustained consumer shift toward premium and “better-for-you” spirits, (2) favorable currency dynamics for the pound against the euro and yen, and (3) tightening global alcohol-tax regimes that pressure volume growth but can be offset by price-elastic premiumization.
For a deeper quantitative assessment, you may want to explore Diageo’s metrics on the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 4.68b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 3.50 > 1.0 |
| NWC/Revenue: 20.36% < 20% (prev 21.43%; Δ -1.06% < -1%) |
| CFO/TA 0.18 > 3% & CFO 9.03b > Net Income 4.68b |
| Net Debt (22.20b) to EBITDA (9.00b): 2.47 < 3 |
| Current Ratio: 1.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (557.0m) vs 12m ago -0.85% < -2% |
| Gross Margin: 59.58% > 18% (prev 0.60%; Δ 5898 % > 0.5%) |
| Asset Turnover: 69.35% > 50% (prev 61.45%; Δ 7.91% > 0%) |
| Interest Coverage Ratio: 6.36 > 6 (EBITDA TTM 9.00b / Interest Expense TTM 1.28b) |
Altman Z'' 3.06
| A: 0.14 (Total Current Assets 17.50b - Total Current Liabilities 10.71b) / Total Assets 49.32b |
| B: 0.21 (Retained Earnings 10.27b / Total Assets 49.32b) |
| C: 0.17 (EBIT TTM 8.13b / Avg Total Assets 48.04b) |
| D: 0.32 (Book Value of Equity 11.62b / Total Liabilities 36.14b) |
| Altman-Z'' Score: 3.06 = A |
Beneish M -3.38
| DSRI: 0.56 (Receivables 3.13b/4.85b, Revenue 33.32b/28.74b) |
| GMI: 1.00 (GM 59.58% / 59.73%) |
| AQI: 0.97 (AQ_t 0.45 / AQ_t-1 0.47) |
| SGI: 1.16 (Revenue 33.32b / 28.74b) |
| TATA: -0.09 (NI 4.68b - CFO 9.03b) / TA 49.32b) |
| Beneish M-Score: -3.38 (Cap -4..+1) = AA |
What is the price of DEO shares?
Over the past week, the price has changed by +4.40%, over one month by +9.46%, over three months by +11.02% and over the past year by -9.76%.
Is DEO a buy, sell or hold?
- StrongBuy: 3
- Buy: 1
- Hold: 2
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the DEO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 104.9 | 8.2% |
| Analysts Target Price | 104.9 | 8.2% |
| ValueRay Target Price | 89.5 | -7.6% |
DEO Fundamental Data Overview February 03, 2026
P/E Forward = 10.4167
P/S = 2.548
P/B = 4.5631
P/EG = 0.5955
Revenue TTM = 33.32b USD
EBIT TTM = 8.13b USD
EBITDA TTM = 9.00b USD
Long Term Debt = 20.82b USD (from longTermDebt, last quarter)
Short Term Debt = 3.04b USD (from shortTermDebt, last quarter)
Debt = 24.40b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.20b USD (from netDebt column, last quarter)
Enterprise Value = 73.78b USD (51.58b + Debt 24.40b - CCE 2.20b)
Interest Coverage Ratio = 6.36 (Ebit TTM 8.13b / Interest Expense TTM 1.28b)
EV/FCF = 10.55x (Enterprise Value 73.78b / FCF TTM 7.00b)
FCF Yield = 9.48% (FCF TTM 7.00b / Enterprise Value 73.78b)
FCF Margin = 21.00% (FCF TTM 7.00b / Revenue TTM 33.32b)
Net Margin = 14.03% (Net Income TTM 4.68b / Revenue TTM 33.32b)
Gross Margin = 59.58% ((Revenue TTM 33.32b - Cost of Revenue TTM 13.47b) / Revenue TTM)
Gross Margin QoQ = 58.17% (prev 61.81%)
Tobins Q-Ratio = 1.50 (Enterprise Value 73.78b / Total Assets 49.32b)
Interest Expense / Debt = 2.02% (Interest Expense 492.2m / Debt 24.40b)
Taxrate = 39.32% (302.6m / 769.6m)
NOPAT = 4.93b (EBIT 8.13b * (1 - 39.32%))
Current Ratio = 1.63 (Total Current Assets 17.50b / Total Current Liabilities 10.71b)
Debt / Equity = 2.20 (Debt 24.40b / totalStockholderEquity, last quarter 11.09b)
Debt / EBITDA = 2.47 (Net Debt 22.20b / EBITDA 9.00b)
Debt / FCF = 3.17 (Net Debt 22.20b / FCF TTM 7.00b)
Total Stockholder Equity = 9.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.73% (Net Income 4.68b / Total Assets 49.32b)
RoE = 47.52% (Net Income TTM 4.68b / Total Stockholder Equity 9.84b)
RoCE = 26.52% (EBIT 8.13b / Capital Employed (Equity 9.84b + L.T.Debt 20.82b))
RoIC = 15.92% (NOPAT 4.93b / Invested Capital 31.00b)
WACC = 5.25% (E(51.58b)/V(75.98b) * Re(7.16%) + D(24.40b)/V(75.98b) * Rd(2.02%) * (1-Tc(0.39)))
Discount Rate = 7.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.42%
[DCF Debug] Terminal Value 88.09% ; FCFF base≈6.20b ; Y1≈7.36b ; Y5≈11.47b
Fair Price DCF = 563.2 (EV 335.26b - Net Debt 22.20b = Equity 313.05b / Shares 555.9m; r=5.90% [WACC]; 5y FCF grow 19.96% → 2.90% )
EPS Correlation: -23.10 | EPS CAGR: -72.81% | SUE: 0.0 | # QB: 0
Revenue Correlation: 50.58 | Revenue CAGR: 36.56% | SUE: N/A | # QB: 0
EPS current Year (2026-06-30): EPS=6.48 | Chg30d=-0.015 | Revisions Net=+0 | Growth EPS=-1.1% | Growth Revenue=-2.0%
EPS next Year (2027-06-30): EPS=6.67 | Chg30d=-0.042 | Revisions Net=+0 | Growth EPS=+2.9% | Growth Revenue=+1.5%